These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
100 related items for PubMed ID: 4036003
1. Efficiency of the NIVGRIP inactivated influenza vaccine applied by oral route: evaluation in a community of pre-school children in the period 1981-84. Coban V, Mihail A, Petrescu A, Teodosiu O, Sternberg I. Virologie; 1985; 36(2):79-83. PubMed ID: 4036003 [Abstract] [Full Text] [Related]
2. Results obtained with the NIVGRIP inactivated influenza vaccine applicable by nasal and/or oral route. Petrescu AL, Cajal N. Virologie; 1984; 35(4):307-14. PubMed ID: 6516213 [Abstract] [Full Text] [Related]
3. The experience of the "Stefan S. Nicolau" Institue of Virology in the preparation of administration of inactivated influenza vaccines applicable by nasal or oral route. Petrescu A, Cajal N, Broniţki A, Mihail A, Teodosiu O, Popescu G, Isaia G, Popescu A. Virologie; 1977; 28(3):213-7. PubMed ID: 898654 [Abstract] [Full Text] [Related]
4. Effect of the oral administration of NIVGRIP inactivated influenza vaccine on virus carriage in the nasopharynx of children aged 0-5 years. Isaia G, Teodosiu O, Athanasiu P, Petrescu A, Dumitrescu G. Virologie; 1985; 36(4):269-72. PubMed ID: 3004017 [Abstract] [Full Text] [Related]
5. [Pharyngeal viral population in 3- to 6-year-old children before and after influenza immunization using the NIVGRIP vaccine administered orally]. Pârvu C, Petrescu A, Coban V. Virologie; 1986; 37(4):263-7. PubMed ID: 3548031 [Abstract] [Full Text] [Related]
6. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children. Piedra PA, Gaglani MJ, Kozinetz CA, Herschler GB, Fewlass C, Harvey D, Zimmerman N, Glezen WP. Pediatrics; 2007 Sep; 120(3):e553-64. PubMed ID: 17698577 [Abstract] [Full Text] [Related]
11. [Importance of influenza in the child. Intranasal influenza vaccine: another systematic vaccination?]. Moraga Llop FA, Campins Martí M. An Esp Pediatr; 2000 Oct; 53(4):299-304. PubMed ID: 11523509 [No Abstract] [Full Text] [Related]
12. Neutralizing influenza antibodies, IgA and total protein in the nasopharyngeal secretions of subjects vaccinated by nasal route with the inactivated influenza vaccine prepared in the "Stefan S. Nicolau" Institute of Virology. Petrescu A, Mihail A, Samuel I, Teodosiu O, Isaia G, Ganea E, Motaş C. Virologie; 1979 Oct; 30(2):109-15. PubMed ID: 111408 [Abstract] [Full Text] [Related]
13. [Complex studies of virology, microbiology, biochemistry and epidemiology in the adults of a semi-closed community vaccinated against influenza with the inactivated NIVGRIP vaccine intranasally]. Steiner N, Ionită I, Zaharia CN, Petrescu A, Ciocîrlie I, Stafie D, Dicu A, Stanciu A, Muşat G. Rev Roum Virol; 1992 Oct; 43(1-2):47-58. PubMed ID: 1283825 [Abstract] [Full Text] [Related]
18. Dynamics of neutralizing secretory influenza antibodies after nasal administration of the NIVGRIP trivalent influenza vaccine. Petrescu A, Steiner N, Trăilescu G, Teodosiu O, Mihăilescu M, Berca C. Virologie; 1985 Oct; 36(3):187-94. PubMed ID: 4071977 [Abstract] [Full Text] [Related]
20. Optimizing protection against influenza in children eligible for the vaccine for children program. Hull HF, O'Connor H. Pediatr Infect Dis J; 2010 Oct; 29(10):910-4. PubMed ID: 20431426 [Abstract] [Full Text] [Related] Page: [Next] [New Search]